Fig. 2

The prevalence of dysgeusia in the study population.The frequency distribution of dysgeusia in mild-advanced fibrosis (≤ F3) compared with ACLD, and in cACLD compared with dACLD patients. ACLD: advanced chronic liver disease; cACLD: compensated advanced chronic liver disease; dACLD: decompensated advanced chronic liver disease. Chi-square test analysis. Statistically significant differences (p < 0.05)